Effects of Qishengyiqi prescription on cardiomyocyte apoptosis and collagen volume fraction in rats with myocardial infarction

LIU Yue,QI Xin,LIU Ke-qiang
DOI: https://doi.org/10.11656/j.issn.1672-1519.2013.08.16
2013-01-01
Abstract:[Objective] To study the effects of Qishengyiqi prescription on cardiomyocyte apoptosis,myocardial infarction size and collagen volume fraction in rats with myocardial infarction(MI).[Methods] The rats with myocardial infarction were randomized into 3 groups: the group A(sham operation with thorax opening without coronary artery deligation,n=10),the group B(MI only,n=19),the group C [n=14,treated with Qishenyiqi extractum,100 mg/(kg·d)×28 after AMI,n=14].After treatment for 4 weeks,the infarct size,myocardial apoptosis index,mean density(MD) of Bcl-2,Bax protein and the collagen volume fraction were monitored.[Results] MD of Bcl2 protein in the group B and C were more weaker than those of group A(P<0.05),MD of Bax protein,the collagen volume fraction in the group B and C were stronger than those of group A.MD of Bcl-2 protein in the group C was stronger than those of the group B(P<0.05),the infarct size,MAI,MD of Bax protein and the collagen volume fraction were minor than those of the group B(P<0.05).[Conclusion] Qishenyiqi can relieve the left ventricular remodeling,improve the cardiac function and protect the heart in rats with myocardia infarction by inhibiting myocardium apoptosis and myocardial fibrosis.
What problem does this paper attempt to address?